[go: up one dir, main page]

HK1021860A1 - Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating - Google Patents

Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating

Info

Publication number
HK1021860A1
HK1021860A1 HK99105804A HK99105804A HK1021860A1 HK 1021860 A1 HK1021860 A1 HK 1021860A1 HK 99105804 A HK99105804 A HK 99105804A HK 99105804 A HK99105804 A HK 99105804A HK 1021860 A1 HK1021860 A1 HK 1021860A1
Authority
HK
Hong Kong
Prior art keywords
coated
clavunalate
amoxycllin
filmcoating
preparing polymer
Prior art date
Application number
HK99105804A
Other languages
English (en)
Inventor
Creighton Pierce Conley
Nigel Philip Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1021860(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1021860A1 publication Critical patent/HK1021860A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK99105804A 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating HK1021860A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
HK1021860A1 true HK1021860A1 (en) 2000-07-07

Family

ID=10754044

Family Applications (5)

Application Number Title Priority Date Filing Date
HK99105804A HK1021860A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
HK01107178A HK1036404A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK03101681.9A HK1050992A1 (zh) 1994-04-23 1998-09-21 含有藥物配方的阿莫西林和克拉維酸
HK00104976A HK1027024A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavunalate
HK98110787A HK1009936A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavulanate

Family Applications After (4)

Application Number Title Priority Date Filing Date
HK01107178A HK1036404A1 (en) 1994-04-23 1998-09-21 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK03101681.9A HK1050992A1 (zh) 1994-04-23 1998-09-21 含有藥物配方的阿莫西林和克拉維酸
HK00104976A HK1027024A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavunalate
HK98110787A HK1009936A1 (en) 1994-04-23 1998-09-21 Polymer coated tablet comprising amoxycillin and clavulanate

Country Status (35)

Country Link
US (1) US6051255A (zh)
EP (5) EP0758235B1 (zh)
JP (1) JP3622975B2 (zh)
CN (1) CN1134258C (zh)
AP (2) AP564A (zh)
AT (6) ATE223706T1 (zh)
AU (1) AU684949B2 (zh)
BG (1) BG62842B1 (zh)
BR (1) BR9507502A (zh)
CA (1) CA2188496A1 (zh)
CZ (2) CZ11376U1 (zh)
DE (5) DE69528204T2 (zh)
DK (4) DK1093813T3 (zh)
DZ (1) DZ1876A1 (zh)
ES (4) ES2182754T3 (zh)
FI (1) FI964249A0 (zh)
GB (1) GB9408117D0 (zh)
GR (2) GR3035031T3 (zh)
HK (5) HK1021860A1 (zh)
HU (1) HU228399B1 (zh)
IL (1) IL113433A (zh)
MA (1) MA23528A1 (zh)
MY (1) MY115351A (zh)
NO (1) NO310703B1 (zh)
NZ (1) NZ285080A (zh)
OA (1) OA10377A (zh)
PL (1) PL316966A1 (zh)
PT (4) PT758235E (zh)
RO (1) RO116997B1 (zh)
RU (1) RU2152213C1 (zh)
SA (1) SA95160343B1 (zh)
SI (1) SI0758235T1 (zh)
SK (1) SK282594B6 (zh)
WO (1) WO1995028927A1 (zh)
ZA (1) ZA953236B (zh)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IL123563A (en) * 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
AU6496498A (en) * 1997-02-07 1998-08-26 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
EA002595B1 (ru) * 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
EP1023065A1 (en) * 1997-08-29 2000-08-02 Dsm N.V. Granules free of excipients
AU747099B2 (en) 1997-10-31 2002-05-09 Pharmacia Corporation Gellan gum tablet coating
MXPA01009808A (es) 1999-04-01 2002-04-24 Dsm Nv Aglomerados por cristalizacion.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
IE20000271A1 (en) * 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) * 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2003210925A1 (en) * 2002-02-07 2003-09-02 Rutgers, The State University Antibiotic polymers
KR100967782B1 (ko) * 2002-02-14 2010-07-05 글락소 그룹 리미티드 N-((1-N-부틸-4-피페리디닐)메틸)-3,4-디하이드로-2H-(1,3)옥사지노(3,2-a)인돌-10-카복스아미드 또는 그의 염을포함하는 제약 조성물, 및 건식 과립화를 포함하는 그의제조 방법
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
US8758820B2 (en) * 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
DE602005023965D1 (de) 2004-03-08 2010-11-18 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
JP5000491B2 (ja) 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
SI2477611T1 (sl) * 2009-09-18 2017-07-31 Sanofi Formulacije tablete (Z)-2-ciano-3-hidroksi-but-2-enojska kislina-(4'-trifluormetilfenil)-amida z izboljšano stabilnostjo
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
IE20000271A1 (en) * 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
HK1027024A1 (en) 2001-01-05
EP1093813B1 (en) 2002-10-16
WO1995028927A1 (en) 1995-11-02
ES2180251T3 (es) 2003-02-01
AP9600868A0 (en) 1996-10-31
DE69521799T2 (de) 2002-06-13
ZA953236B (en) 1995-12-27
PT761218E (pt) 2001-03-30
RU2152213C1 (ru) 2000-07-10
ATE226074T1 (de) 2002-11-15
IL113433A (en) 2003-06-24
DE69528204D1 (de) 2002-10-17
PT978276E (pt) 2003-01-31
DK0978276T3 (da) 2003-01-20
AU2406895A (en) 1995-11-16
AT5350U1 (de) 2002-06-25
EP1243267A2 (en) 2002-09-25
BG62842B1 (bg) 2000-09-29
HUT76335A (en) 1997-08-28
DZ1876A1 (fr) 2002-02-17
DE29522153U1 (de) 2000-04-06
AU684949B2 (en) 1998-01-08
EP0978276A3 (en) 2000-04-12
EP1093813A3 (en) 2001-05-30
BR9507502A (pt) 1997-09-02
ATE203161T1 (de) 2001-08-15
CZ294168B6 (cs) 2004-10-13
FI964249L (fi) 1996-10-22
SI0758235T1 (en) 2001-10-31
NZ285080A (en) 1998-05-27
NO310703B1 (no) 2001-08-20
HU9602922D0 (en) 1996-12-30
JP3622975B2 (ja) 2005-02-23
HK1050992A1 (zh) 2003-07-18
EP1093813A2 (en) 2001-04-25
EP0761218B1 (en) 2000-10-11
DE69521799D1 (de) 2001-08-23
CN1134258C (zh) 2004-01-14
AT5349U1 (de) 2002-06-25
SA95160343B1 (ar) 2005-05-04
ATE196845T1 (de) 2000-10-15
PL316966A1 (en) 1997-03-03
HK1009936A1 (en) 1999-06-11
EP0978276B1 (en) 2002-09-11
FI964249A0 (fi) 1996-10-22
DE69528608T2 (de) 2003-06-26
US6051255A (en) 2000-04-18
AP9500733A0 (en) 1995-04-30
PT1093813E (pt) 2003-02-28
AP564A (en) 1996-11-21
SK282594B6 (sk) 2002-10-08
IL113433A0 (en) 1995-07-31
CZ11376U1 (cs) 2001-07-12
DE69519093T2 (de) 2001-07-19
ES2152485T3 (es) 2001-02-01
EP0758235A1 (en) 1997-02-19
ES2161288T3 (es) 2001-12-01
HU228399B1 (en) 2013-03-28
DK0758235T3 (da) 2001-10-29
HK1036404A1 (en) 2002-01-04
CN1149829A (zh) 1997-05-14
OA10377A (en) 2001-11-21
DK0761218T3 (da) 2000-12-18
EP0761218A1 (en) 1997-03-12
BG100933A (en) 1997-07-31
GR3036844T3 (en) 2002-01-31
EP1243267A3 (en) 2002-10-30
CZ309096A3 (en) 1997-04-16
JPH09512027A (ja) 1997-12-02
DE69528608D1 (de) 2002-11-21
MA23528A1 (fr) 1995-12-31
PT758235E (pt) 2001-10-31
DE69528204T2 (de) 2003-08-07
NO964488L (no) 1996-12-17
DE69519093D1 (de) 2000-11-16
SK135496A3 (en) 1997-05-07
EP0758235B1 (en) 2001-07-18
ES2182754T3 (es) 2003-03-16
GR3035031T3 (en) 2001-03-30
EP0978276A2 (en) 2000-02-09
DK1093813T3 (da) 2003-02-17
CA2188496A1 (en) 1995-11-02
ATE223706T1 (de) 2002-09-15
MY115351A (en) 2003-05-31
GB9408117D0 (en) 1994-06-15
RO116997B1 (ro) 2001-09-28
NO964488D0 (no) 1996-10-22

Similar Documents

Publication Publication Date Title
HK1021860A1 (en) Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
HUP9900339A3 (en) Water-soluble copolymers, process for producing the same and their use
EP0761712A3 (en) Bioabsorbable polymer and process for preparing the same
AU3955795A (en) Biocompatible coating, medical device using the same and methods
AU5769998A (en) Antimicrobial polymers comprising quaternary ammonium groups, their use for making a material with antimicrobial properties and methods for preparing them
EP0837162A4 (en) MULTI-FILAMENT CLAVED THREAD TAPE, METHOD AND DEVICE FOR MANUFACTURING THE SAME
HUP9802994A3 (en) Polymer material, process for its production and use thereof
HK1020034A1 (en) Powder filling systems, apparatus and methods.
AU6584496A (en) Polyolefin film containing cycloolefin polymer, process for the production thereof, and the use thereof
GB2287473B (en) Coated polymer devices for biomedical applications
EP0810243A4 (en) AQUEOUS RESIN DISPERSION AND PROCESS FOR PRODUCING THE SAME
HU9403137D0 (en) Polymer system, process for producing said polymer system and using said polymer system
BR9711032B1 (pt) comprimido de maleato de trimebutina revestido com pelÍcula e processo de preparo do mesmo.
EP0661331A3 (en) Polymer containing silicon, process for its preparation and monomer.
HUP9801246A3 (en) Graft copolymers based on mono-, oligo- and polysaccharides, process for preparing the same and their use
HK1032140A1 (en) Worked-wire products, and method and apparatus fo r manufacturing the same.
AU6926496A (en) New cyclic guanidines, process for preparing the same and medicaments
AU3029795A (en) Comoulded multi-layer polymer blend system, and shaped articles derived therefrom
EP0761711A3 (en) Thermoplastic copolymer based on polyvinyl alcohol, process for its production and use
AU6091196A (en) A polymerization process, apparatus and polymer
ZA948195B (en) Resin-containing, biaxially oriented polypropylene film, process for the production thereof, and the use thereof.
EP0739912A3 (en) Polymers with a high acid value, their use and process for their preparation
AU1055801A (en) Nitrogen-free dlc film coated plastic container, and method and apparatus for manufacturing the same
AU7040998A (en) Polysaccharide-based thermoplastic material, process for preparing the same and use thereof
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150418